38 Global Improvement and Patient Satisfaction: Results From a Long-Term, Open-Label, Rollover Study of Valbenazine in Tardive Dyskinesia

CNS Spectrums - United Kingdom
doi 10.1017/s1092852919000312
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Cambridge University Press (CUP)

Related search

Treatment of Tardive Dyskinesia With Tetrabenazine or Valbenazine: A Systematic Review

Journal of Comparative Effectiveness Research
Health Policy
2018English

The Effects of Valbenazine on Tardive Dyskinesia in Older and Younger Patients

International Journal of Geriatric Psychiatry
PsychiatryGerontologyGeriatricsMental Health
2019English

Indirect Treatment Comparison of Valbenazine and Deutetrabenazine Efficacy and Safety in Tardive Dyskinesia

Journal of Comparative Effectiveness Research
Health Policy
2019English

Tardive Dyskinesia

2019English

Tardive Dyskinesia.

BMJ
1979English

Long-Term Metformin Treatment in Adolescents With Obesity and Insulin Resistance, Results of an Open Label Extension Study

Nutrition and Diabetes
Internal MedicineEndocrinologyMetabolismDiabetes
2018English

High Patient Satisfaction With a Simplified BRCA1/2 Testing Procedure: Long-Term Results of a Prospective Study

Breast Cancer Research and Treatment
Cancer ResearchOncology
2018English

Long-Term Safety and Tolerability of Oral Tofacitinib in Patients With Crohn’s Disease: Results From a Phase 2, Open-Label, 48-Week Extension Study

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2019English

Safety and Efficacy of Tofacitinib for Up to 9.5 Years in the Treatment of Rheumatoid Arthritis: Final Results of a Global, Open-Label, Long-Term Extension Study

Arthritis Research & Therapy
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy